Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-030965

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 24, 2015
Accepted (ET)
Apr 28, 2015 · 3:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF4Apr 24, 2015A925$0.00A70,152D
Common StockF1,F3holding———972,100IBy Knott Partners, L.P.
Common StockF1,F3holding———233,361IBy Shoshone Partners, L.P.
Common StockF1,F3holding———40,796IBy Knott Partners Offshore Master Fund, L.P.
Common StockF2,F3holding———1,666IBy Managed Account C
Common StockF2,F3holding———1,843IBy immediate family member

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F5$89.75Apr 24, 2015A2,754A—Apr 24, 2025Common Stock2,7542,754D
Non-Qualified Stock Option (right to buy)F6$67.53holding————Jun 4, 2024Common Stock3,3123,312D

Explanation of responses